Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation (Oncogene, (2020), 39, 9, (1846-1859), 10.1038/s41388-019-1104-z)

Academic Article

Abstract

  • © 2019, The Author(s), under exclusive licence to Springer Nature Limited. The original version of this Article omitted the following from the Acknowledgements: Professor Stebbing sits on SABs for Celltrion, Singapore Biotech, Vor Biopharma, TLC Biopharmaceuticals and Benevolent AI, has consulted with Lansdowne partners, Vitruvian and Social Impact Capital and Chairs the Board of Directors for BB Biotech Healthcare Trust and Xerion Healthcare. This has now been corrected in both the PDF and HTML versions of the Article.
  • Published In

  • Oncogene  Journal
  • Digital Object Identifier (doi)

    Author List

  • Jin Y; Bao H; Le X; Fan X; Tang M; Shi X; Zhao J; Yan J; Xu Y; Quek K
  • Start Page

  • 2027
  • Volume

  • 39
  • Issue

  • 9